Executive Summary
The 50 filings reveal a concentrated wave of Indian corporate insolvencies (8+ companies entering CIRP, including Spright Agro, TV Vision, and Sun Granite Export), signaling severe distress in small-cap industrials and real estate.
Healthcare M&A consolidation is a key theme, with Krishna Institute of Medical Sciences (KIMS) executing four acquisitions totaling up to ₹135 Cr, though most targets are loss-making, indicating a long-term strategic play. Large-cap M&A dominates in the US: IES Holdings acquired DBM Global for ~$691M (its largest deal), and Clarivate sold its Life Sciences segment for $600M to sharpen focus. SPAC activity remains active with Tavia Acquisition Corp's sponsor change and Melar Acquisition Corp's business combination vote set for October 22. Delisting risks are rising: FibroGen and Virtuix received Nasdaq non-compliance notices, while Bed Bath & Beyond's warrants were finally delisted. Period-over-period trends show extreme revenue collapses (Visagar Polytex from ₹71,017 lakh to zero) and rapid growth in early-stage companies (Meesho's investee revenue grew 6x to ₹16 Cr but remains unprofitable). The overall sentiment is predominantly negative or neutral, with only a few positive signals from well-capitalized acquirers.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Schedule 13D · 8-K
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from September 29, 2026.
Investment Signals (12)
- IES Holdings ↓ (BULLISH)▲
Completed its largest acquisition of DBM Global for ~$691M, funded with cash and stock; DBM generated ~$1.5B revenue (12 months ended June 2026) and adds 4,000 employees; expected to generate substantial cash flow to repay debt
- Clarivate ↓ (BULLISH)▲
Sold Life Sciences & Healthcare segment to Altaris for $600M, sharpening focus on Academia & Government and IP segments; proceeds will reduce debt and strengthen balance sheet; Q3 results and updated guidance due Nov 3
- Krishna Institute of Medical Sciences (Sarvottam Health Care) (BULLISH)▲
Acquiring up to 51% stake for up to ₹80 Cr; target shows steady revenue growth from ₹74.36 Cr (FY24) to ₹84.83 Cr (FY26), positive trajectory; completion expected by Oct 31, 2026
- Endurance Technologies ↓ (BULLISH)▲
Acquired 100% of Anna Milena and Fondalpress for €12.34M; Fondalpress net worth €20.40M implies effective net consideration of ~€2.24M after cash balances, a significant discount; strengthens European aluminium die-casting capabilities
- Tavia Acquisition Corp ↓ (BULLISH)▲
New sponsor Fog Cutter Holdings (25.6% stake) with experienced management (Andrew Wiederhorn as Chairman/CEO) and extended business combination deadline to March 2027; sponsor assumed trust contributions up to $60K/month
- Melar Acquisition Corp I ↓ (BULLISH)▲
SEC declared S-4 effective for business combination with Everli (Italian e-grocery marketplace); shareholder vote Oct 22; combined entity to trade as EVRL; asset-light marketplace model
- Simulations Plus ↓ (BULLISH)▲
Acquisition by Altaris affiliates completed at $18.50/share cash, taking company private; combined with Chemical Computing Group to create broader drug development platform; premium to prior trading
- Spright Agro ↓ (BEARISH)▲
NCLT admitted CIRP petition under Section 9, IRP appointed; powers of board suspended; materiality 10/10 – severe financial distress, equity likely worthless
- TV Vision ↓ (BEARISH)▲
CIRP initiated via Form G invitation for EOI; resolution professional appointed; listed on BSE/NSE; materiality 9/10 – high risk of equity wipeout
- Visagar Polytex ↓ (BEARISH)▲
Composite scheme to write off accumulated losses of ₹30.89 Cr; turnover collapsed from ₹71,017 lakh (FY20) to nil (FY25); fire in Sep 2024 forced indefinite manufacturing suspension; equity at risk
- FibroGen (Kyntra Bio) (BEARISH)▲
Received Nasdaq delisting determination for failing to meet $50M assets/revenue standard; hearing requested but no assurance of continued listing; stock trading under KYNB
- Bed Bath & Beyond (Neighborhood Intelligence) (BEARISH)▲
Final delisting of warrants effective Oct 6, 2026 under Rule 12d2-2(a)(2); marks end of winding down process after name change in Aug 2025
Risk Flags (10)
- Spright Agro / Insolvency↓ [HIGH RISK]▼
CIRP admitted by NCLT Ahmedabad; IRP appointed; board suspended; materiality 10 – highest risk of total equity loss
- ▼
Nominee of successful resolution applicant withdrew willingness to hold 81.55% of paid-up capital; listing of shares still pending with exchange; implementation of NCLT-approved plan in jeopardy
- Visagar Polytex / Operational Shutdown↓ [HIGH RISK]▼
Fire incident in Sep 2024 forced indefinite suspension of manufacturing; turnover zero in FY25; accumulated losses ₹30.89 Cr; scheme requires capital reduction and fresh infusion but viability uncertain
- Interworld Digital / Default↓ [HIGH RISK]▼
Defaulted on vehicle loan (₹0.06 Cr) and has ₹2.23 Cr other unsecured loans outstanding; attributes default to former MD who allegedly fraudulently shifted assets; legal recourse uncertain
- Madhucon Projects / Default↓ [HIGH RISK]▼
Disclosed defaults on loan repayments with total financial indebtedness ₹130.68 Cr; though filing shows nil current default, the disclosure indicates ongoing stress with PNB as secured lender
- Adia Nutrition / Governance Deadlock↓ [MODERATE RISK]▼
Sold 30% of Adia Labs for $1.5M but voting power split 50/50; buyer has option for additional 10% (expires Sep 2028); deadlock risk could impede strategic decisions
- Baron Infotech / CIRP Delay↓ [MODERATE RISK]▼
NCLAT oral status quo order on appeal by unsuccessful resolution applicant; may delay resolution process; monitoring committee noted the order
- Kapil Raj Finance / Conditional Open Offer↓ [MODERATE RISK]▼
Open offer at ₹2.24/share conditional on shareholder approval of preferential issue and regulatory clearances; acquirers may withdraw if statutory approvals refused; execution risk
- BeyondSpring / Non-Cash Consideration↓ [MODERATE RISK]▼
Sold subsidiaries for license to clinical trial data and funding commitment; no cash received; contingent consideration (clawback) may require return of equity if enrollment targets missed; pro forma still shows operating losses and no revenue
- Virtuix Holdings / Nasdaq Non-Compliance↓ [MODERATE RISK]▼
Failed to meet $50M MVLS requirement; compliance deadline March 29, 2027; may need to transfer to Nasdaq Capital Market; delisting risk if not regained
Opportunities (10)
-
Four acquisitions totaling up to ₹135 Cr across hospitals in Sangli, Guntur, Kakinada, and Kompally; Sarvottam (Kakinada) shows steady revenue growth; KIMS is leveraging O&M expertise to expand in underpenetrated markets; long-term value creation if turnaround of loss-making targets succeeds
- IES Holdings / Structural Growth↓ (OPPORTUNITY)◆
Acquisition of DBM Global adds ~$1.5B revenue and 4,000 employees, establishing a new Structural line of business; expected to generate substantial cash flow to repay acquisition debt; IES's largest deal to date signals confidence in integration
- Endurance Technologies / Asset Play↓ (OPPORTUNITY)◆
Acquired Fondalpress at €12.34M vs net worth of €20.40M; effective net consideration only ~€2.24M after cash; Anna Milena has steady turnover; strengthens European die-casting footprint at attractive valuation
- Clarivate / Refocus Catalyst↓ (OPPORTUNITY)◆
Divestiture of Life Sciences & Healthcare for $600M allows debt reduction and sharper focus on higher-growth Academia & Government and IP segments; Q3 results and updated guidance on Nov 3 could provide upside if core segments outperform
- Meesho / Kirana Tech Bet↓ (OPPORTUNITY)◆
Additional investment up to ₹50 Cr in Retail Pulse Labs (B2B kirana platform); investee revenue grew from ₹2.7 Cr (FY24) to ₹16.04 Cr (FY26) – nearly 6x; continued losses but rapid scaling in India's kirana ecosystem; potential for high growth if path to profitability emerges
- Melar Acquisition Corp / SPAC Arbitrage↓ (OPPORTUNITY)◆
Business combination with Everli (Italian e-grocery) vote on Oct 22; S-4 effective; combined entity to trade as EVRL; asset-light marketplace model; typical SPAC arbitrage opportunity if deal closes
- Tavia Acquisition Corp / New Sponsor Catalyst↓ (OPPORTUNITY)◆
Experienced management team (Wiederhorn, Kuick) taking over; extended deadline to March 2027 provides runway; sponsor has skin in the game with monthly trust contributions; potential for attractive de-SPAC target
- Hiliks Technologies / Open Offer Arbitrage↓ (OPPORTUNITY)◆
Mandatory open offer at ₹72/share for 26% of expanded capital; total cash consideration ₹26.58 Cr; acquirers and PACs will hold 25.59% post-transaction; offer not conditional on minimum acceptance – shareholders can tender at a fixed price
- Privi Speciality Chemicals / Amalgamation Synergies↓ (OPPORTUNITY)◆
Scheme to merge two wholly-owned subsidiaries; NCLT dispensed with most creditor meetings; shareholder meeting Oct 27; consolidation expected to reduce costs and simplify structure; potential for margin improvement
- BirlaNu / Amalgamation Approval↓ (OPPORTUNITY)◆
NCLT Hyderabad approved amalgamation of wholly owned subsidiary Clean Coats; no consideration issued; operational synergies and management simplification; effective after Mumbai NCLT approval
Sector Themes (6)
- Indian Small-Cap Insolvency Wave◆
At least 8 filings involve CIRP initiation or ongoing insolvency proceedings (Sun Granite, Privi Speciality, Hi-Tech Gears, ARSS Infrastructure, Unitech International, TV Vision, Baron Infotech, Spright Agro). Most targets are non-operational or severely distressed, indicating a systemic stress in Indian small-cap industrials and real estate. Investors should avoid equity exposure in these names.
- Healthcare M&A Consolidation in India◆
KIMS alone filed four acquisition announcements totaling up to ₹135 Cr across different hospital assets. The pattern shows listed hospital chains aggressively acquiring O&M entities and loss-making facilities to expand bed capacity and geographic reach. Near-term earnings dilution likely, but long-term consolidation play.
- Large-Cap M&A Driving Structural Change◆
IES Holdings ($691M) and Clarivate ($600M) represent significant transformative deals. Both are using M&A to refocus business lines and strengthen balance sheets. The scale suggests confidence in integration and future cash flows.
- SPAC Activity Resurgence◆
Three SPAC-related filings (Tavia Acquisition, Southern Cross Acquisition II, Melar Acquisition Corp) show continued activity. Tavia's sponsor change and Melar's business combination vote highlight that SPACs remain a viable path to public markets despite regulatory scrutiny.
- Delisting and Compliance Risks Rising◆
FibroGen, Virtuix, and Bed Bath & Beyond all face delisting or have been delisted. Nasdaq's enforcement of listing standards (MVLS, assets/revenue) is creating a wave of compliance challenges for micro-cap and pre-revenue companies. Investors should monitor compliance deadlines closely.
- Cross-Border Capital Flows into Indian Entities◆
Multiple filings involve Indian companies investing in overseas subsidiaries (LEAP India into UAE, Repro India into Sharjah) or foreign acquirers targeting Indian companies (Hiliks, RR Metalmakers open offers). This reflects growing international interest in Indian mid-cap assets.
Watch List (8)
-
Expressions of Interest due Oct 19, 2026; resolution plans due Dec 18; watch for any credible resolution applicants given non-operational status with zero assets.
-
Meeting of equity shareholders on Oct 27, 2026 to consider amalgamation scheme; approval is key to unlocking synergies.
-
Extraordinary general meeting on Oct 22, 2026 to vote on Everli merger; if approved, combined company to trade as EVRL; watch for shareholder approval and deal closing.
-
Open offer opens Nov 16 and closes Nov 30, 2026 at ₹2.24/share; conditional on preferential issue approval; watch for regulatory clearances and shareholder approval.
- FibroGen (Kyntra Bio) / Nasdaq Hearing👁
Hearing requested before Nasdaq Hearings Panel; extension up to 180 days possible; watch for Panel decision and any compliance plan.
-
Must regain $50M MVLS by March 29, 2027; may apply to transfer to Nasdaq Capital Market; monitor market value and any reverse stock split or other actions.
-
Earnings call on Nov 3, 2026; full-year guidance update to reflect Life Sciences divestiture; watch for margin improvement in remaining segments and debt reduction progress.
- KIMS Acquisitions / Completion Deadlines👁
Sarvottam acquisition expected by Oct 31, 2026; Splendid Hospitals by Mar 31, 2027; Insignia Healthcare over 12-24 months; monitor regulatory approvals and integration updates.
Filing Analyses
(50)
06-10-2026
Sun Granite Export Ltd. has initiated the Corporate Insolvency Resolution Process (CIRP) by publishing Form G on October 2, 2026, inviting Expressions of Interest (EOI) from resolution applicants. The company is non-operational with no revenue, no fixed assets, and no employees as per its FY 2024-25 audited financials. The deadline for EOI submission is October 19, 2026, with resolution plans due by December 18, 2026.
- · The company's PAN is AADCS8998P and CIN is L14102OR1991PLC002834.
- · The registered office is at VILL PANIORA, PO PALASPUR VIA JANLA, Khordha, Khurda, Odisha – 752054, India.
- · The company has no fixed assets and is not operational.
- · The last date for submission of EOI is 19-10-2026.
- · The provisional list of resolution applicants will be issued on 29-10-2026.
- · The final list of prospective resolution applicants will be issued on 13-11-2026.
- · The last date for submission of resolution plans is 18-12-2026.
- · The company is not registered as an MSME.
- · The Resolution Professional's IP Registration No. is IBBI/IPA-002/IP-N01023/2020-2021/13276, with AFA validity up to 31.12.2026.
- · The process-specific email ID is [email protected].
06-10-2026
Enact Technologies Private Limited, along with Penumatsa Venkata Raju and Boyapati Venkata Lakshmi Narasimha Swamy (Acquirers) and three PACs, has triggered a mandatory open offer under SEBI SAST Regulations to acquire up to 36,92,000 equity shares (26.00% of expanded capital) of Hiliks Technologies at ₹72 per share, for a total cash consideration of ₹26,58,24,000. The offer follows a Share Purchase Agreement dated October 05, 2026 to acquire 5,00,000 shares (3.52%) from Extros Developers Private Limited, which will result in a change of control. The Acquirers and PACs currently hold 17.88% and will hold 25.59% post-transaction on a fully diluted basis.
- · The open offer is triggered under Regulation 3(1) and Regulation 4 of the SEBI SAST Regulations.
- · The Detailed Public Statement (DPS) is to be published on or before October 12, 2026.
- · The offer is not conditional on any minimum level of acceptance.
- · The Acquirers and PACs have adequate financial resources to meet the offer obligations.
- · The offer is not a competing offer.
- · The target company's equity shares are listed on BSE (Scrip Code: 539697) and MSEI (Scrip Code: HILIKS).
- · The ISIN of the target company is INE966Q01010.
06-10-2026
The Board of Shristi Infrastructure Development Corporation Limited approved a Scheme of Arrangement to demerge the Krishnagar Sentrum undertaking into its wholly owned subsidiary, Shristi Realty Holdings Limited, with an Appointed Date of October 1, 2026. The undertaking recorded turnover of INR 1,281.72 Lakh in FY 2025-26, representing 18.37% of SIDCL’s standalone turnover; however, the demerger remains subject to stock-exchange observations, shareholder and creditor approvals, NCLT sanction and other statutory approvals. No cash consideration is payable, with eligible SIDCL shareholders instead receiving 2 fully paid-up equity shares of SRHL for every 9 fully paid-up SIDCL shares.
- · The Scheme transfers Krishnagar Sentrum, including attributable assets, liabilities, contracts, employees, licenses, permits, approvals and properties, to SRHL as a going concern on an as-is-where-is basis.
- · Krishnagar Sentrum is a mixed-use project in Krishnanagar, Nadia District, West Bengal, comprising residential, retail, entertainment, hospitality and lifestyle components.
- · The Board meeting was held on October 06, 2026, commenced at 3:00 P.M. and concluded at 4:50 P.M.
- · The share entitlement ratio was supported by a report dated October 06, 2026 from Omnifin Valuation Services (OPC) P Ltd and a fairness opinion dated October 06, 2026 from Corpwis Advisors Private Limited.
- · Listing of SRHL is proposed on BSE Limited and The Calcutta Stock Exchange Limited, subject to requisite approvals and relaxation under Rule 19(7) of the Securities Contracts (Regulation) Rules, 1957.
- · The Scheme may result in minor changes to the stated SRHL shareholding because fractional shares may be consolidated and issued to a trustee.
06-10-2026
Fog Cutter Holdings, LLC has acquired a 25.6% stake in Tavia Acquisition Corp. (TAVIR) by purchasing 2,243,333 ordinary shares and 249,107 private units from the prior sponsor for $250,000, becoming the new sponsor. The transaction closed on October 1, 2026, and triggered a management overhaul: Andrew Wiederhorn was appointed Chairman and CEO, Kenneth Kuick became CFO, while Kanat Mynzhanov and Askar Mametov resigned as officers and Mametov left the board. The new sponsor has also assumed responsibility for monthly trust account contributions of up to $60,000 to extend the business combination deadline to March 5, 2027.
- · The prior sponsor retained 1,500,000 ordinary shares and no private units after the sale.
- · Fog Cutter Holdings assumed obligations under the Registration Rights Agreement (Dec 3, 2024) and the Letter Agreement (Dec 3, 2024), excluding Sections 7 and 8.
- · The administrative services agreement between the SPAC and prior sponsor terminated at closing, with accrued fees waived by the prior sponsor.
- · The new sponsor must file a Form 8-K disclosing the transaction, management changes, and any potential target conflicts.
- · The SPAC's board determined the transaction increases the likelihood of consummating a business combination.
06-10-2026
Amber Enterprises India Limited has incorporated a wholly owned subsidiary, Amber Digital Technologies Private Limited, to commence the business of manufacturing mobile phones. The subsidiary was incorporated on September 18, 2026, with a total equity infusion of ₹1,00,000 (₹1 Lakh) at a 100% shareholding. This move marks Amber's strategic diversification into the mobile phone manufacturing segment, although the investment is relatively small at the initial stage.
- · The subsidiary was incorporated on 18th September 2026 in India.
- · The industry classification is Electronics and Telecommunication.
- · No governmental or regulatory approvals were required for the incorporation.
- · The consideration is in cash; no share swap involved.
06-10-2026
Privi Speciality Chemicals Limited has filed a scheme of amalgamation with the National Company Law Tribunal (NCLT) to merge two wholly-owned/related entities — Privi Fine Sciences Private Limited (Transferor Company 1) and Privi Biotechnologies Private Limited (Transferor Company 2) — into itself (Transferee Company). The NCLT has dispensed with meetings of creditors and shareholders of the transferor companies and of creditors of the transferee company, but ordered a meeting of equity shareholders of Privi Speciality Chemicals Limited on 27 October 2026 to consider the scheme. The appointed date for the amalgamation is 1 October 2025, and the scheme is intended to consolidate operations, reduce costs, and simplify the corporate structure.
- · The NCLT order dated 7 September 2026 dispensed with meetings of members, secured and unsecured creditors of Transferor Company 1; members and unsecured creditors of Transferor Company 2; and secured and unsecured creditors of the Transferee Company.
- · A meeting of equity shareholders of Privi Speciality Chemicals Limited (Transferee Company) will be held on 27 October 2026 through OAVM to consider the scheme.
- · The appointed date for the amalgamation is 1 October 2025.
- · The Board of Directors of all three companies approved the scheme in meetings held on 19 December 2025.
- · The Transferee Company obtained No Objection Letters from NSE (ref. NSE/LIST/52681 dated 5 May 2026) and BSE (ref. DCS/AMAL/RD/R37/53/2026-27 dated 6 May 2026).
- · Transferor Company 2 (Privi Biotechnologies Private Limited) is a wholly owned subsidiary of the Transferee Company; upon amalgamation, its shares held by the Transferee Company will be cancelled and no new shares will be issued.
- · Shareholders of Transferor Company 1 will receive 1 equity share of ₹10 each of the Transferee Company for every 135 fully paid equity shares of ₹10 each held in Transferor Company 1.
- · Representations regarding the scheme may be made to the NCLT within 30 days from receipt of the notice.
06-10-2026
Zodiac Energy Limited incorporated a wholly owned subsidiary, ZODIAC ENERGY IPP-4 PRIVATE LIMITED, on October 06, 2026, with a nominal share capital of ₹10,00,000 and initial paid-up capital of ₹1,00,000. The subsidiary is a Special Purpose Vehicle (SPV) for solar power generation and EPC projects, aligning with the company's business expansion strategy. No financial performance data (e.g., turnover) is available as the entity is newly incorporated.
- · The subsidiary was incorporated under CIN U35100GJ2026PTC184717.
- · The subsidiary is classified as a Special Purpose Vehicle (SPV) for solar power generation and EPC activities.
- · No governmental or regulatory approvals were required for the incorporation.
- · The consideration was cash, with Zodiac Energy subscribing to 100% of the initial paid-up share capital of ₹1,00,000.
- · The subsidiary has zero turnover as of incorporation date.
06-10-2026
LEAP India Ltd has invested approximately INR 9.64 crore (USD 1,000,000) to subscribe to 999,999,999 equity shares of its wholly owned UAE subsidiary, LEAP MENA Holdings Limited. The newly incorporated subsidiary will be used to infuse equity or debt into its own subsidiary, LEAP Pallet Pooling Trading LLC, for business investment. The transaction is an arm's-length related-party investment under the automatic FEMA route.
- · LEAP MENA Holdings Limited was incorporated on July 1, 2026, under Abu Dhabi Global Market Companies Regulations, 2020.
- · The subsidiary is authorized to carry on the business of a holding company.
- · The investment is made under the automatic route in accordance with FEMA.
- · The exchange rate used for the remittance was $1 = INR 96.44.
- · The equity shares have a face value of $0.001 each.
- · No governmental or regulatory approval was required for the investment.
06-10-2026
06-10-2026
AXISCADES Technologies Limited has incorporated a step-down subsidiary, XIDA DEEPTECH PRIVATE LIMITED, in India on October 05, 2026, through its holding company XIDA PRIVATE LIMITED. The new entity will operate in electronics, semiconductor, artificial intelligence and deep tech sectors. AXISCADES holds no direct shareholding and no shares were allotted, but exercises indirect control as the ultimate holding company.
06-10-2026
Visagar Polytex Limited filed a Composite Scheme of Arrangement under Sections 230-232, 66, 62 and 42 of the Companies Act, 2013. The scheme proposes a reduction of share capital to write off accumulated losses of Rs. 30,89,52,786/- as at March 31, 2026, followed by a preferential issue of equity shares and warrants to infuse fresh capital. However, the company has experienced severe and sustained losses for multiple years, with turnover declining from Rs. 71,016.96 lakh in FY2019-20 to Nil in FY2024-25, and a fire incident in September 2024 forced indefinite suspension of manufacturing operations.
- · The scheme involves reduction of share capital under Section 66, followed by preferential issue of equity shares and warrants.
- · Accumulated losses of Rs. 30,89,52,786/- as at March 31, 2026.
- · A fire incident on September 4, 2024 forced indefinite suspension of manufacturing operations.
- · Turnover declined to Nil in FY2024-25 from Rs. 2,821.06 lakh in FY2023-24 (100% decline).
- · The company has not turned a profit for several years; accumulated losses have eroded net worth.
- · The reduction of share capital does not involve any payment to shareholders.
06-10-2026
Interworld Digital Ltd disclosed defaults on loan repayments for the quarter ending September 30, 2026, with total financial indebtedness of ₹2.29 Cr. The company defaulted on the last installment of a vehicle loan from Kotak Mahindra Prime Limited (outstanding ₹0.06 Cr), which it attributes to the past Managing Director, Mr. Man Mohan Gupta, who allegedly fraudulently shifted business assets and retains possession of the vehicle. The company also has ₹2.23 Cr in other short-term unsecured loans outstanding, with interest and charges of ₹0.05 Cr due but unpaid.
- · The company attributes the default to the past Managing Director, Mr. Man Mohan Gupta, who allegedly fraudulently shifted the entire business and intellectual property to other entities and retains possession of the vehicle.
- · The company has requested Mr. Man Mohan Gupta to return the vehicle or clear the outstanding debts, but he is not cooperating.
- · The disclosure is made pursuant to SEBI Circular No. SEBI/HO/CFD/CMDl/CIR/P/2019/140 dated 21st November, 2019.
06-10-2026
RR Metalmakers India Limited has disclosed a corrigendum to the Public Announcement, Detailed Public Statement, and Draft Letter of Offer for an Open Offer by RB International Holdings Limited and two individual acquirers. The offer aims to acquire up to 23,42,295 equity shares of the company from public shareholders under SEBI takeover regulations. This filing is a procedural disclosure and does not contain any financial performance data or operational metrics.
- · The corrigendum was published in newspapers on October 06, 2026.
- · The offer is made under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
- · The filing is made under Regulation 30 of SEBI (LODR) Regulations, 2015.
06-10-2026
Adia Med, Inc. (ADIA) completed the sale of a 30% membership interest in its subsidiary Adia Labs LLC to Live Oak Health LLC (QCM Biologics) for $1.5M on September 30, 2026. The deal includes $1M in cash and a $500K promissory note, and grants the buyer an option to purchase an additional 10% for $500K. While Adia retains 70% economic ownership, voting power is split 50/50 between the parties, creating a governance deadlock risk.
- · The promissory note is secured by a first-priority pledge of the Purchased Units until paid in full.
- · The Option to purchase up to 10 additional units expires on September 30, 2028.
- · If the Option is exercised in full, Adia would own 60% and Buyer 40% of the units, but voting power remains 50/50.
- · Deadlock resolution requires mediation in Seminole County, Florida; if mediation fails within 30 days, either member may pursue a buy-sell remedy.
- · Neither member may dissolve the Labs Company solely because of deadlock without a court order or written agreement.
- · The Labs Company has a first right of refusal on any proposed transfer of units to a third party.
- · Quarterly distributions: after expenses, taxes, and a 10% reserve, 90% of remaining cash is distributed pro rata to members within 30 days after quarter-end.
- · The Purchase Agreement is governed by Florida law, except Nevada law governs Adia's internal corporate affairs; venue is in Seminole County, Florida or Middle District of Florida.
- · The Purchased Units and option units are restricted and not registered under the Securities Act of 1933.
06-10-2026
Nukleus Office Solutions Limited informed BSE that Mr. Anurag Gupta, Senior Management Personnel (Lead Manager – Facilities), has resigned effective October 30, 2026, due to personal reasons after mutual discussion with HR and the CEO. The company stated there is no other material reason for his resignation.
- · Mr. Gupta's resignation is effective from the close of business hours on October 30, 2026.
- · The resignation follows mutual discussion with the HR and CEO of the company.
- · No other material reason for the resignation was cited.
06-10-2026
Baba Arts Ltd has informed BSE that a board meeting will be held on October 9, 2026 to take note of the acquisition of the promoter's shareholding by an unnamed Acquirer pursuant to an SPA and SAST Regulations. The meeting will also appoint the Acquirer's nominees as additional directors, accept resignations of existing directors and key managerial personnel, reconstitute board committees, appoint a Managing Director and CFO, and approve the annual report for FY2026. This signals a change in control and management of the company.
- · Board meeting date: October 9, 2026 at 1:30 p.m. at registered office in Mumbai.
- · Agenda includes: appointment of internal auditor for FY2026-27, fixing date/time/mode of 27th Annual General Meeting, and other matters incidental to change in management and control.
- · The Acquirer is not named in the filing.
06-10-2026
Madhucon Projects Limited disclosed defaults on payment of interest/repayment of principal on loans to banks/financial institutions for the quarter ended September 30, 2026. The filing reports total financial indebtedness of ₹130.68 Cr (including non-fund based), but states nil current default amount (principal, interest, and other) and nil total outstanding fund-based borrowings. The annexure lists Punjab National Bank (formerly OBC) as a secured lender, but no specific default amount is provided.
- · The filing is made pursuant to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2019/140 dated November 21, 2019.
- · Nature of obligation is both fund and non-fund based.
- · Date of default reported as September 30, 2026.
- · The annexure lists only one lender: Punjab National Bank (formerly OBC), with security classified as secured.
- · No current default amount (principal, interest, or other) is disclosed; all entries are 'Nil'.
06-10-2026
The Hi-Tech Gears Limited has informed the exchanges that the NCLAT, due to lack of time, could not hear the matter on October 5, 2026, and has rescheduled the hearing to October 7, 2026. The NCLAT has also directed the continuation of the interim stay on the Corporate Insolvency Resolution Process (CIRP) that was originally granted on September 3, 2024. The company remains under the protection of the stay, with the next hearing scheduled in two days.
- · The appeal is listed as Company Appeal (AT) (Insolvency) No. 1734 of 2024.
- · The interim stay on the CIRP was originally granted on September 3, 2024.
- · The next hearing is scheduled for October 7, 2026.
- · The appellant is Naveen Jain, a Company Secretary/Shareholder of The Hi-Tech Gears Ltd.
- · The respondents include Happy Forgings Ltd. and the Interim Resolution Professional (IRP), Mr. Deepak Thukral.
06-10-2026
ARSS Infrastructure Projects Ltd disclosed that Roger Bravo Secured Development Fund, the nominee of the Successful Resolution Applicant (Ocean Capital Market Limited), has withdrawn its willingness to hold 7,35,00,000 equity shares (about 81.55% of paid-up capital) allotted under the NCLT-approved Resolution Plan. Roger Bravo has given an unconditional no-objection to substitution by the SRA or another nominee. The company will take steps to effect the substitution, but the listing of these shares remains pending with the exchange, creating uncertainty around the implementation of the resolution plan.
- · The NCLT Cuttack Bench approved the Resolution Plan on 29 August 2025 in IA(IB) No. 283/CB/2023 in CP(IB) No. 34/CB/2021.
- · The shares were allotted via PAS-3 filings (SRN- AC2925810 dated 07/04/2026 and SRN- AC0660769 dated 02/01/2026).
- · The application for listing of the shares is still pending with the exchange, and the shares have not yet been credited to the allottee's demat account.
- · Roger Bravo has confirmed it will hold the shares in trust until further instructions and will not exercise any voting or shareholder rights.
- · Roger Bravo has given unconditional no-objection to cancellation/reversal/rectification of the allotment and fresh allotment to another nominee.
06-10-2026
Unitech International Ltd disclosed that the 13th meeting of its Committee of Creditors (CoC) was held on 27.07.2026 via video conferencing, during which the resolution to ratify CIRP expenses incurred by the Resolution Professional was approved. The company remains under Corporate Insolvency Resolution Process (CIRP), with Mr. Nitin Narang serving as Resolution Professional. No financial figures were disclosed in this filing.
- · Meeting date: 27.07.2026 at 12:00 P.M. via Video Conferencing
- · Agenda Item B1 (ratification of CIRP expenses) was approved by the Committee of Creditors
- · Resolution Professional's IBBI Registration Number: IBBI/IPA-002/IP-N00828/2019-2020/12629
- · AFA valid till 30.06.2027
06-10-2026
Laurus Labs Limited has invested INR 12,09,60,500 (₹12.096 Cr) to acquire 1,20,96,050 equity shares of its associate company Kurnool Renewables Private Limited (KRPL) through a rights issue, maintaining its 26% shareholding. This investment follows an earlier intimation dated March 28, 2025, and increases the company's total holding in KRPL to 2,11,68,000 equity shares of INR 10 each.
- · The investment was made by way of a rights issue.
- · The company's shareholding percentage in KRPL remains unchanged at 26%.
- · The investment is a follow-up to an intimation dated March 28, 2025.
06-10-2026
TV Vision Limited has initiated the Corporate Insolvency Resolution Process (CIRP) by issuing Form G (Invitation for Expression of Interest) dated September 28, 2026, as disclosed to the stock exchanges under Regulation 30 of SEBI LODR. The company is now under the control of Resolution Professional Alok Kumar Murarka. This filing marks a formal step in the insolvency proceedings, inviting potential resolution applicants.
- · Form G was published on September 28, 2026, the same day it was dated.
- · The company's registered office is at 7th Floor, Adhikari Chambers, Oberoi Complex, New Link Road, Andheri (W), Mumbai - 400 053.
- · The company is listed on BSE (Scrip No. 540083) and NSE (Symbol: TVVISION).
- · Resolution Professional Alok Kumar Murarka is registered with IBBI under registration number IBBI/IPA-001/IP-P-01934/2019-2020/13006.
06-10-2026
IRM Energy Limited has filed a petition seeking sanction for a Scheme of Amalgamation with Enertech Distribution Management Private Limited. The National Company Law Tribunal (NCLT), Ahmedabad Bench, has ordered a hearing on the petition, and the company has published newspaper advertisements as required under Regulation 30 of SEBI LODR. No financial details of the transaction have been disclosed in this filing.
- · The NCLT Ahmedabad Bench order was dated September 24, 2026.
- · Newspaper advertisements were published in The Indian Express (All India English Edition) and The Sandesh (Ahmedabad Edition) on October 06, 2026.
- · The hearing of the petition is for sanction to the Scheme of Amalgamation.
06-10-2026
Unitech International Ltd, currently under Corporate Insolvency Resolution Process (CIRP), disclosed that its 15th Committee of Creditors (CoC) meeting was held on 20.08.2026 via video conferencing. The CoC approved the ratification of CIRP expenses incurred by the Resolution Professional (RP) as per Regulation 34 of the IBBI (CIRP) Regulations, 2016. No other agenda items or financial figures were disclosed, and the company remains under insolvency proceedings.
- · Filing date: 06.10.2026; letter dated 25.09.2026
- · CoC meeting date: 20.08.2026 at 06:00 P.M. via Video Conferencing
- · Agenda Item B1 (ratification of CIRP expenses) was approved by the CoC
- · RP's IBBI Registration Number: IBBI/IPA-002/IP-N00828/2019-2020/12629
- · RP's AFA valid till 30.06.2027
- · Company scrip code: 531867; scrip name: UNITINT
06-10-2026
Arpit Agarwal, Megha Agarwal, and Arpit Agarwal (HUF) have launched an open offer to acquire up to 9,92,12,282 equity shares (26% of expanded voting capital) of Kapil Raj Finance Ltd. at ₹2.24 per share, pursuant to SEBI (SAST) Regulations triggered by a proposed preferential issue. The offer opens on November 16, 2026 and closes on November 30, 2026, but is conditional on shareholder approval of the preferential issue and other regulatory approvals, creating execution risk. The offer is not conditional on a minimum acceptance level, but oversubscription will be accepted on a proportionate basis, meaning not all tendered shares may be bought.
- · The open offer is triggered by a proposed preferential issue, which itself requires shareholder approval and regulatory clearances.
- · The acquirers may withdraw the offer if statutory approvals are refused (Regulation 23(1)(a)), but cannot withdraw if the preferential issue fails.
- · Tendering period: November 16, 2026 (Monday) to November 30, 2026 (Monday).
- · Identified date for determining public shareholders to receive the letter of offer: October 30, 2026 (Friday).
- · Last date for upward revision in offer price/size: November 12, 2026 (Thursday).
- · Payment of consideration or refund of unaccepted shares to be completed by December 14, 2026 (Monday).
- · In case of oversubscription, acceptance will be on a proportionate basis; a lien will be marked on tendered shares and released for unaccepted shares.
06-10-2026
Arvind Limited has completed the acquisition of 4,600 equity shares (46% stake) in Arvind Global Capability Center Private Limited for cash consideration at face value. The target is a newly incorporated company (April 1, 2026) with nil turnover, focused on providing centralized business support and shared services to group entities. The transaction is a related party transaction executed on an arm's length basis.
- · Arvind GCC was incorporated on April 1, 2026, and has nil turnover and nil size.
- · The acquisition is a related party transaction but done on an arm's length basis.
- · Consideration is cash at face value per share.
- · No governmental or regulatory approvals were required for the acquisition.
06-10-2026
Repro India Limited, through its wholly owned subsidiary Repro Books Limited, has completed the acquisition of 100% equity shares of Repro LLC, making it a step-down wholly owned subsidiary. The acquisition was finalized on October 6, 2026, following share transfer and registration formalities with SHAMS (Sharjah Media City), UAE. No financial details or consideration amounts were disclosed in this filing.
- · The acquisition was initially intimated on August 18, 2026.
- · Repro LLC is based in Sharjah, UAE, under the Sharjah Media City (SHAMS) jurisdiction.
- · Post-acquisition, Repro LLC is a wholly owned subsidiary of Repro Books Limited and a step-down wholly owned subsidiary of Repro India Limited.
06-10-2026
Baron Infotech Ltd, currently under Corporate Insolvency Resolution Process (CIRP), held its 3rd Monitoring Committee meeting on October 6, 2026. The committee noted an oral status quo order from the NCLAT Chennai Bench dated October 1, 2026, in an appeal filed by unsuccessful resolution applicant Vivek Kumar Ratakonda, which may delay the resolution process. No financial figures or operational updates were disclosed in this post-facto intimation.
- · The Monitoring Committee meeting was held on Tuesday, October 6, 2026, starting at 5:00 pm and concluding around 6:55 pm IST.
- · The status quo order was pronounced orally by the NCLAT Chennai Bench on October 1, 2026.
- · The appeal was filed by the unsuccessful resolution applicant, Mr. Vivek Kumar Ratakonda.
- · The company's scrip code on BSE is 532336.
06-10-2026
ACME Solar Holdings Limited has incorporated 18 wholly owned subsidiaries on October 06, 2026, each with a paid-up capital of ₹1,00,000 (10,000 equity shares of ₹10 each). The subsidiaries are set up to undertake businesses related to power generation and renewable energy projects, with 100% cash subscription by the listed entity.
- · The subsidiaries were incorporated in Gurugram, Haryana, India.
- · No governmental or regulatory approvals were required for the incorporation.
- · The consideration was 100% cash subscription to the initial paid-up share capital.
06-10-2026
Endurance Technologies Limited, via its wholly owned Italian subsidiary Endurance Overseas SpA, has acquired 100% of Anna Milena SpA and Fondalpress SpA for €12.34 million in cash. The acquisition strengthens Endurance's aluminium die-casting capabilities in Europe, adding strategically located assets and production capacity. Fondalpress has experienced declining turnover and swung to a loss in its most recent unaudited year, though the effective net consideration is only ~€2.24 million after accounting for the targets' cash balances.
- · Fondalpress's net worth as of Dec 2024 was €20.40 million, against an acquisition cost of €12.34 million.
- · Anna Milena's net worth as of Dec 2024 was €1.40 million; its turnover has been steady at €0.40 million for the last three years.
- · No governmental or regulatory approvals were required, and the transaction closed simultaneously with signing.
- · The acquisition is not a related party transaction and the promoter/promoter group has no interest in the target companies.
06-10-2026
TVS Supply Chain Solutions Limited (TVS SCS) has completed the allotment of 1,99,90,000 equity shares in its subsidiary TVS SCS ALA India Private Limited (formerly TVS Packaging Solutions Private Limited) to itself and ALA Mena, in a 51:49 ratio, pursuant to a Joint Venture Agreement. The transaction, approved by the Target Entity's Board on October 06, 2026, involves a cash consideration of INR 19,99,00,000 (INR Nineteen Crores and Ninety-Nine Lakhs) and aims to expand into India's aerospace and defense sectors. However, the Target Entity's turnover remains insignificant, and the acquisition is expected to contribute to revenue and profit growth only through future business expansion.
- · The Target Entity was a wholly owned subsidiary of TVS SCS prior to the transaction.
- · The Target Entity was incorporated on April 28, 2017, in India.
- · The Target Entity's turnover during the last 3 years was insignificant.
- · The transaction is not a related party transaction; promoters have no interest.
- · No governmental or regulatory approvals are required for the acquisition.
- · The Target Entity is focused on exploring business expansion opportunities in the logistics industry.
06-10-2026
Krishna Institute of Medical Sciences Limited (KIMS) has approved the acquisition of a 6% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli) for an aggregate consideration of ₹15 Crore via primary infusion. The target entity, a quaternary care facility with 316 beds (expandable to 500+), reported a turnover of ₹80.42 Crore but a net loss of ₹23.59 Crore for FY26, indicating the investment is strategic rather than immediately profitable.
- · Target entity was incorporated on 25-11-2016.
- · Target entity reported a net loss (PAT) of ₹23.59 Crore for FY26.
- · The acquisition is not a related party transaction.
- · Completion of acquisition is expected on or before 31-10-2026.
- · Consideration is cash, based on a valuation report by BDO Valuation Advisory LLP dated 05 October 2026.
06-10-2026
Krishna Institute of Medical Sciences Limited (KIMS) has approved the acquisition of up to 51% equity stake in Insignia Healthcare Private Limited (KIMS-SIKHARA), an O&M entity operating a 150-bed hospital in Guntur, Andhra Pradesh. The acquisition will be made via cash at ₹30.35 per share based on a valuation report by BDO Valuation Advisory LLP, with completion expected within 12 to 24 months. The target company reported a turnover of ₹104.5 Cr in FY25 but a net loss of ₹13.28 Cr in FY24-25, indicating a turnaround challenge.
- · The acquisition is not a related party transaction.
- · The target company was incorporated on July 2, 2018.
- · The acquisition will be by way of creeping acquisition over an indicative period of 12 to 24 months.
- · Subsequent acquisitions after the initial purchase will be at cost based on an independent valuer's report.
- · The hospital has the potential to increase capacity from 150 to 200 beds.
06-10-2026
Krishna Institute of Medical Sciences Limited (KIMS) has approved the acquisition of up to 51% equity stake in Sarvottam Health Care Private Limited (Kakinada), an O&M entity, for an aggregate consideration of up to ₹80.00 Crore. The target, operating as Trust Multi Speciality Hospital with 183 beds, reported turnover of ₹84.83 Cr in FY26, ₹81.38 Cr in FY25, and ₹74.36 Cr in FY24, showing steady growth. The acquisition is expected to complete on or before 31.10.2026, with cash consideration based on a BDO valuation report.
- · Target entity incorporated on 19-04-2011
- · Target operates in Kakinada, Andhra Pradesh, India
- · Target has a total built-up area of approximately 9847.23 square meters on company-owned land of 3001.36 square yards
- · Target's net worth is ₹50.30 Crore as per FY26 data
- · Target's PAT is ₹70.55 Crore as per FY26 data
- · Acquisition is not a related party transaction
- · Acquisition is a strategic investment, with KIMS being the O&M partner of the target
- · No governmental or regulatory approvals required for the acquisition
- · Consideration is cash-based, based on BDO valuation report dated 05 October 2026
- · Target turnover growth slowed to 4.24% in FY26 from 9.44% in FY25
06-10-2026
Krishna Institute of Medical Sciences Limited (KIMS) has approved the acquisition of up to 22% equity stake in Splendid Hospitals Private Limited (Kompally) for an aggregate consideration of up to ₹40.00 Crore via primary infusion. The target, incorporated in September 2022, reported a turnover of ₹1.39 Crore and a net loss of ₹8.92 Crore for FY 2025-26, with a net worth of ₹38.69 Crore. While the investment is strategic for KIMS as the O&M partner, the target's financials show significant losses and minimal revenue, indicating a high-risk, long-term growth play.
- · The acquisition is expected to be completed on or before 31.03.2027.
- · The consideration is cash-based, with valuation determined by BDO Valuation Advisory LLP report dated 05th October 2026.
- · Splendid Hospitals was incorporated on 20-09-2022 and is located in Kompally, Telangana, India.
- · The target has the potential to expand to over 225+ beds and is equipped with latest medical infrastructure and multiple operation theatres.
- · The acquisition does not fall within related party transactions.
06-10-2026
The Hon'ble National Company Law Tribunal (NCLT), Ahmedabad Bench, has admitted a petition under Section 9 of the Insolvency and Bankruptcy Code, 2016, initiating the Corporate Insolvency Resolution Process (CIRP) against Spright Agro Ltd. The powers of the Board of Directors have been suspended, and Rajesh Jasti has been appointed as the Interim Resolution Professional (IRP) to manage the company as a going concern.
- · NCLT order number: CP(IB)/86(AHM)/2026 dated 24/09/2026
- · Application filed under Section 9 of IBC by Agrirevolve Trading Private Limited
- · IRP's IBBI Registration No: IBBI/IPA-001/IP-P02317/2020-21/13469
- · Email for correspondence: [email protected]
- · Company CIN: L01100GJ1994PLC117990
06-10-2026
Meesho Ltd's board approved an additional investment of up to INR 50,00,00,000 (Fifty Crores) in Retail Pulse Labs Private Limited (RPLPL), a B2B kirana tech platform, as part of the ongoing acquisition of Kirana Club Pte. Ltd. The board also executed an amendment to the original share purchase agreement, but the total consideration of INR 2,02,08,52,202.40 (Two Hundred Two Crores Eight Lakhs Fifty-Two Thousand Two Hundred Two and Forty Paise) and scope remain unchanged. RPLPL reported audited turnover of INR 16.04 Crore for FY2025-26 with a net loss of INR (1.60) Crore, showing rapid revenue growth from INR 2.7 Crore in FY2023-24 but continued unprofitability.
- · RPLPL reported a net loss of INR (1.60) Crore for FY2025-26 despite strong revenue growth.
- · No tranche of the acquisition has been completed as of the filing date.
- · The additional investment of INR 50 Crore is to be made within one year from closing of the first tranche.
- · RPLPL was incorporated on October 7, 2021, and operates a B2B platform connecting kirana retailers with FMCG brands.
06-10-2026
Spright Agro Ltd. has entered Corporate Insolvency Resolution Process (CIRP) following an order by the Hon'ble National Company Law Tribunal (NCLT), Ahmedabad Bench dated 24/09/2026. The company has published public announcements in Financial Express (English) and Jai Hind-Ahmedabad (Gujarati) on 27/09/2026, and appointed Rajesh Jasti as the Interim Resolution Professional (IRP). This marks a significant negative event for the company, indicating severe financial distress.
- · NCLT Ahmedabad Bench order no. CP(IB)/86(AHM)/2026 dated 24/09/2026 initiated the CIRP.
- · Public announcements published on 27/09/2026 in Financial Express (English) and Jai Hind-Ahmedabad (Gujarati).
- · IRP Rajesh Jasti holds IBBI Registration No: IBBI/IPA-001/IP-P02317/2020-21/13469.
- · Email for correspondence: [email protected]
06-10-2026
BirlaNu Limited (formerly HIL Limited) has received NCLT Hyderabad Bench approval for the amalgamation of its wholly owned subsidiary, Clean Coats Private Limited, into itself. The scheme, approved on October 6, 2026, is intended to create operational synergies, reduce redundancies, and simplify management. However, the scheme will only become effective after the NCLT Mumbai Bench also approves the Transferor Company's petition and certified copies are filed with the respective Registrars of Companies.
- · The Transferor Company (Clean Coats Private Limited) is a wholly owned subsidiary of the Transferee Company (BirlaNu Limited).
- · No consideration will be issued by BirlaNu Limited upon amalgamation since Clean Coats is a wholly owned subsidiary; the entire share capital of Clean Coats will be cancelled.
- · The scheme was approved by the Board of Directors of Clean Coats on February 12, 2025, and by the Board of BirlaNu on February 13, 2026.
- · The scheme does not require prior approval from SEBI or stock exchanges under Regulation 37(6) of SEBI LODR as it involves a wholly owned subsidiary.
- · The scheme will become effective only after the NCLT Mumbai Bench approves the Transferor Company's petition and certified copies are filed with the respective Registrars of Companies.
- · BirlaNu Limited changed its name from HIL Limited to BirlaNu Limited on March 19, 2025.
06-10-2026
Kyntra Bio, Inc. (formerly FibroGen) received a Nasdaq Staff Determination on September 30, 2026, stating it failed to demonstrate compliance with Listing Rule 5450(b) (requiring at least $50 million in total assets and revenue) and did not meet alternative stockholders' equity or market value standards. The company has requested a hearing before a Nasdaq Hearings Panel, which stays the delisting and allows continued trading under 'KYNB' pending the Panel's decision. However, there is no assurance the Panel will grant continued listing, and the company faces potential delisting if compliance is not regained.
- · Company received delisting determination on September 30, 2026, with a compliance deadline of September 29, 2026.
- · Company has requested a hearing before a Nasdaq Hearings Panel, which stays suspension and Form 25-NSE filing pending the Panel's decision.
- · Extension period could be up to 180 days from the Staff delisting Determination pursuant to Listing Rule 5815(c)(1)(A).
- · Company's common stock will continue trading on Nasdaq Global Select Market under symbol 'KYNB' pending the Panel's decision.
- · Previously disclosed on April 2, 2026, that the company was not in compliance with Nasdaq Listing Rule 5450(b)(3)(A).
06-10-2026
IES Holdings completed the acquisition of DBM Global for approximately $691 million, funded with cash and stock, establishing a new Structural line of business. DBM Global generated about $1.5 billion in revenue for the twelve months ended June 30, 2026, and adds approximately 4,000 employees. The transaction is IES's largest acquisition to date and is expected to generate substantial cash flow to repay acquisition-related borrowings.
- · IES acquired 100% of DBM Global common stock, including ~91.2% held by INNOVATE Corp.
- · The stock split (two-for-one) was effected on August 21, 2026, and share count was adjusted accordingly.
- · Cash consideration includes $35M payment to INNOVATE for joint Section 338(h)(10) election.
- · DBM Global operates brands including Schuff Steel, Banker Steel, GrayWolf, DBM Vircon, and Aitken.
- · DBM Global has more than 2 million square feet of fabrication and operating facilities across the U.S.
- · IES expects substantial cash flow from both IES and DBM Global to rapidly repay acquisition-related borrowings.
06-10-2026
VineBrook Homes Trust, Inc. filed Amendment No. 3 to its Schedule TO, announcing preliminary results of its issuer tender offer to purchase up to $30 million (909,090 shares) of its Class A common stock at $33.00 per share. The offer expired on October 5, 2026, and the company issued a press release on October 6, 2026, with preliminary results. The filing does not disclose the number of shares tendered or the final acceptance amount, leaving the outcome uncertain.
- · The tender offer commenced on September 4, 2026 and expired at 5:00 PM Eastern Time on October 5, 2026.
- · The offer was an issuer tender offer subject to Rule 13e-4.
- · The company issued a press release on October 6, 2026, announcing preliminary results, attached as Exhibit 99(a)(5)(D).
- · The filing is Amendment No. 3, with prior amendments on September 22 and September 28, 2026.
- · The company also entered into a Credit Agreement dated September 28, 2026, with VB Thirteen, LLC and VB Fourteen, LLC as borrowers and The Ohio State Life Insurance Company as lender (Exhibit 99(b)).
06-10-2026
Acura Pharmaceuticals, Inc. filed an 8-K to amend the loan schedule to its Secured Promissory Note with Abuse Deterrent Pharma, LLC, increasing the aggregated principal from $2,319,279 to $11,294,279 as of October 2, 2026. The amendment reflects additional loans totaling $8,975,000 made between December 2022 and October 2026, including 16 new loans in 2026. This is a routine debt schedule update, not a merger or acquisition.
- · Loan #62 dated 6/24/2026 was $200,000, larger than the typical $100,000 loans.
- · Loan #63 dated 7/17/2026 was $200,000.
- · Loan #64 dated 8/14/2026 was $200,000.
- · Loan #65 dated 9/18/2026 was $100,000.
- · Loan #66 dated 10/02/2026 was $100,000.
- · The amendment was signed on October 6, 2026.
06-10-2026
Southern Cross Acquisition II Corp. announced that holders of its units may elect to separately trade the ordinary shares, warrants, and rights included in its units, commencing on or about October 8, 2026. The separate securities will trade on Nasdaq under the symbols SCAT, SCATW, and SCATR, while units not separated will continue to trade under SCATU. This is a routine operational update with no financial impact.
- · Separation of units to commence on or about October 8, 2026.
- · Ordinary shares, warrants, and rights will trade under symbols SCAT, SCATW, and SCATR respectively.
- · Units not separated will continue to trade under symbol SCATU.
- · Press release dated October 6, 2026 attached as Exhibit 99.1.
06-10-2026
Simulations Plus, Inc. (Nasdaq: SLP) announced the completion of its acquisition by affiliates of Altaris, LLC for $18.50 per share in cash, taking the company private. The transaction, originally announced on June 16, 2026, results in Simulations Plus being combined with Altaris portfolio company Chemical Computing Group (CCG) to create a broader drug development platform. Simulations Plus will continue to operate under its own name and brand within the combined organization.
- · Altaris manages $10 billion of equity capital and has invested in more than 50 healthcare companies since 2003.
- · The combined organization will span drug discovery, modeling, simulation, and development.
- · Simulations Plus common stock will no longer trade on the Nasdaq Global Select Market.
06-10-2026
Nasdaq Stock Market LLC filed a Form 25-NSE to delist the warrants of Neighborhood Intelligence, Inc. (formerly Bed Bath & Beyond, Inc.) under Section 12(b) of the Securities Exchange Act of 1934, effective October 6, 2026. The delisting is based on Rule 12d2-2(a)(2), which applies when the entire class of securities is called for redemption, maturity, or retirement. This marks the final step in the company's winding down process following its name change from Bed Bath & Beyond, Inc. in August 2025.
- · The delisting is effective as of October 6, 2026.
- · The company changed its name from Bed Bath & Beyond, Inc. to Neighborhood Intelligence, Inc. on August 25, 2025.
- · The delisting is based on SEC Rule 12d2-2(a)(2) for securities called for redemption, maturity, or retirement.
- · The filing was made by Nasdaq, not the company itself.
06-10-2026
Melar Acquisition Corp. I (MACIU) announced that the SEC has declared effective its S-4 registration statement for the proposed business combination with Everli Global Inc., an Italian e-grocery marketplace. The extraordinary general meeting to vote on the deal is set for October 22, 2026. Upon closing, the combined company is expected to trade on Nasdaq under the ticker 'EVRL'.
- · The Merger Agreement was entered into on July 30, 2025.
- · Record date for shareholder voting is September 28, 2026.
- · Everli was founded in 2014 and operates an asset-light, marketplace-based model in Italy.
- · The combined company will be named Everli Global Holdings Inc. and will trade under tickers EVRL (Class A common stock) and EVRLW (warrants).
06-10-2026
BeyondSpring Inc. completed the sale of its ownership interests in BeyondSpring Ltd. (including its subsidiaries Bulin and SEED Technology) and SEED Therapeutics Inc. to Biolin Investment Limited on September 30, 2026, in exchange for noncash consideration — a license to use data from the DUBLIN-4 clinical trial and the investor's commitment to fund the trial. The deconsolidation of the two disposal groups resulted in a preliminary estimated gain of $52.9M on the pro forma balance sheet, but the company recognized no value for the contingent consideration (future trial data and a clawback provision). Pro forma net loss from continuing operations attributable to BeyondSpring Inc. improved from $(3.1M) to $(3.7M) for the six months ended June 30, 2026, and from $(8.5M) to $(8.0M) for FY2025, reflecting the removal of the disposal groups' losses; however, the company still has no revenue and continues to report significant operating losses.
- · No cash consideration was received for the sale; consideration is entirely noncash (license to DUBLIN-4 data and funding commitment).
- · The contingent consideration (Bulin Data and Clawback) is accounted for under the gain-contingency model (ASC 450-30) and no value has been recognized in the pro forma financials.
- · If patient enrollment target is not met within 3 years, the investor must return a portion of equity interests; if shortfall is 90% or greater, 100% of equity must be returned.
- · The company retained approximately 29% voting power in SEED (via one common share and Series A-1 preferred shares) and the right to elect two directors, but no longer controls SEED.
- · Pro forma total assets decreased from $14.6M to $21.1M (increase due to equity investment remeasurement), while total liabilities dropped from $50.6M to $3.8M.
- · Pro forma shareholders' deficit improved from $(36.0M) to $17.3M (positive equity).
- · Revenue remains zero in all periods presented (as reported and pro forma).
- · The company waived approximately $3.7M in intercompany debt owed by a Bulin subsidiary before closing.
06-10-2026
Virtuix Holdings Inc. (VTIX) received a Nasdaq Staff Notice on September 30, 2026, stating it no longer meets the minimum Market Value of Listed Securities (MVLS) requirement of $50,000,000 for continued listing on the Nasdaq Global Market, nor the alternative total assets/revenue standard. The company has until March 29, 2027, to regain compliance, during which its Class A common stock will continue trading on Nasdaq under the symbol 'VTIX.' Management is evaluating options, including a potential transfer to the Nasdaq Capital Market, but there is no assurance of regaining compliance.
- · The Company also fails to meet the alternative total assets and total revenue standard under Nasdaq Listing Rule 5450(b)(3)(A).
- · The Company may appeal a delisting determination to a Nasdaq Hearings Panel if it fails to regain compliance by the Compliance Date.
- · The Company may consider applying to transfer its listing to The Nasdaq Capital Market, subject to Nasdaq's approval.
06-10-2026
Clarivate completed the sale of its Life Sciences & Healthcare segment to Altaris for $600 million, sharpening its focus on Academia & Government and Intellectual Property segments. Proceeds will be used to reduce debt and strengthen the balance sheet. The company will report Q3 2026 results on November 3, 2026, and update full-year 2026 guidance to reflect the divestiture.
- · Transaction was previously announced on July 6, 2026.
- · Clarivate will report Q3 2026 financial results on November 3, 2026.
- · Full year 2026 guidance will be updated to reflect the divestiture.
- · Proceeds intended to reduce debt and strengthen balance sheet.
- · Post-divestiture portfolio consists of Academia & Government and Intellectual Property segments.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Global High-Priority Regulatory Events
September 28, 2026
Global High-Priority Regulatory Events — September 28, 2026
September 25, 2026
Global High-Priority Regulatory Events — September 25, 2026
September 24, 2026
Global High-Priority Regulatory Events — September 24, 2026
September 23, 2026
Global High-Priority Regulatory Events — September 23, 2026
🇺🇸 More from United States
View all →September 29, 2026
US Pre-Market SEC Filings Roundup — September 29, 2026
US Pre-Market SEC Filings Roundup
September 29, 2026
US SEC Filings Daily Market Digest — September 29, 2026
US SEC Filings Daily Market Digest
September 29, 2026
US IPO Pipeline SEC S-1 Filings — September 29, 2026
US IPO Pipeline SEC S-1 Filings
September 29, 2026
US Material Events SEC 8-K Filings — September 29, 2026
US Material Events SEC 8-K Filings